![Robert Foster](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert Foster
Direktor/Vorstandsmitglied bei
Transcriptome Sciences
Profil
Robert T.
Foster was the founder of Ciclofilin Pharmaceuticals, Inc. (2014) as Chief Executive Officer & Director, Isotechnika Pharma, Inc. (1993) as Chairman, President, CEO & Director, and Aurinia Pharmaceuticals, Inc. (1993) as Director.
Current jobs include Director at Transcriptome Sciences and Member at Institute of Corporate Directors.
Former jobs include President & Chief Executive Officer at Isotechnika, Inc., Director at Alberta Economic Development Authority, Director at BioAlberta, Chief Executive & Scientific Officer at Hepion Pharmaceuticals, Inc. (2018), Associate Professor at the University of Alberta (1997), and Member-Management Board at Alberta Science & Research Authority.
Aktive Positionen von Robert Foster
| Unternehmen | Position | Beginn |
|---|---|---|
Institute of Corporate Directors
 Institute of Corporate Directors Miscellaneous Commercial ServicesCommercial Services Promotes governance and develops leadership skills | Corporate Officer/Principal | - |
Transcriptome Sciences | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Robert Foster
| Unternehmen | Position | Ende |
|---|---|---|
| AURINIA PHARMACEUTICALS INC. | Vorstandsvorsitzender | 25.10.2013 |
| HEPION PHARMACEUTICALS, INC. | Vorstandsvorsitzender | 04.12.2023 |
Ciclofilin Pharmaceuticals, Inc.
 Ciclofilin Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Develops cyclophilin inhibitors for infectious, inflammatory, and degenerative diseases | Gründer | 10.06.2016 |
Isotechnika Pharma, Inc.
 Isotechnika Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics | Vorstandsvorsitzender | 23.10.2013 |
University of Alberta
 University of Alberta Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01.12.1997 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
57
Beziehungen ersten Grades
11
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
Isotechnika, Inc.
 Isotechnika, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops immunosuppressive therapeutic drugs | Health Technology |
Hepion Pharmaceuticals, Inc.
 Hepion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drug therapy for treatment of chronic liver diseases | Health Technology |
Ciclofilin Pharmaceuticals, Inc.
Ciclofilin Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Develops cyclophilin inhibitors for infectious, inflammatory, and degenerative diseases | Health Technology |
University of Alberta
University of Alberta Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Institute of Corporate Directors
Institute of Corporate Directors Miscellaneous Commercial ServicesCommercial Services Promotes governance and develops leadership skills | Commercial Services |
Alberta Economic Development Authority
 Alberta Economic Development Authority General GovernmentGovernment Provides an independent voice on economic issues that matter to Alberta | Government |
BioAlberta
 BioAlberta Miscellaneous Commercial ServicesCommercial Services Operates a member-driven association that represents and promotes the province's vibrant and diverse life sciences industry | Commercial Services |
Alberta Science & Research Authority | |
Isotechnika Pharma, Inc.
Isotechnika Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics | Health Technology |
Aurinia Pharmaceuticals, Inc.
 Aurinia Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics | Health Technology |
Transcriptome Sciences |
